BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Speedel Group 

Hirschgasslein 11

Basel    CH - 4051  Switzerland
Phone: 41-61-206-40-00 Fax: 41-61-206-40-01


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Speedel Group Release: SPP100 (Tekturna/Rasilex) Reduces Left Ventricular Hypertrophy 4/1/2008 9:31:18 AM    More...
Speedel Group Holds Annual R&D Day 3/31/2008 11:17:50 AM    More...
Speedel Group Announces A New Series Of Renin Inhibitors 2/16/2006 11:13:20 AM    More...
Speedel Group Release: SPP301 Phase IIb Results In Diabetic Nephropathy Presented At ASN 11/14/2005 10:39:21 AM    More...
Speedel Brings In CHF47.8M To Advance Pipeline Projects 10/19/2005 5:12:49 PM    More...
Speedel Raises CHF 47.8 Million In Private Funding Round 10/19/2005 5:12:47 PM    More...
Novartis' (NVS) Latest Phase III And II Data With SPP100 (Aliskiren) Reconfirm Speedel's Previous Clinical Studies For The Treatment Of Hypertension 10/19/2005 5:12:31 PM    More...
Professor Karl-Heinz Altmann Joins Speedel Scientific & Technical Advisory Board 10/19/2005 5:12:16 PM    More...
Speedel Group Release: Successful Outcome Of Aliskiren, The First-In-Class Renin Inhibitor, Vs. Irbesartan, In A 650 Patient Hypertension Study, Recently Completed By Novartis (NVS) 10/19/2005 5:10:49 PM    More...
Speedel Pharmaceuticals, Inc. Appoints Rolf Hanggi To Board Of Directors 10/19/2005 5:10:27 PM    More...
12